Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Continuous Glucose Monitoring (CGM) and Sensor-Augmented Pump Therapy (SAP)

BuchGebunden
143 Seiten
Deutsch
UNI-MED, Bremenerschienen am15.06.2012
Verfügbare Formate
BuchGebunden
EUR29,80
E-BookPDF1 - PDF WatermarkE-Book
EUR29,80

Produkt

Details
ISBN/GTIN978-3-8374-1321-2
ProduktartBuch
EinbandartGebunden
Erscheinungsjahr2012
Erscheinungsdatum15.06.2012
ReiheUNI-MED Science
Reihen-Nr.Science
Seiten143 Seiten
SpracheDeutsch
Gewicht406 g
Illustrationenw. numerous col. figs.
Artikel-Nr.15304893
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
1. State of the art in the technical development of modern insulin pumps 101.1. Historical development of insulin pumps 101.2. Change in the indications for CSII 121.3. Characteristics and functionality of modern insulin pumps 131.3.1. Currently available insulin pumps 131.3.2. The "treasures of insulin pump therapy" 131.3.2.1. Overview 131.3.2.2. "CSII treasure number 1": multibasal rate administration 161.3.2.3. "CSII treasure number 2": different bolus options 171.3.2.4. "CSII treasure number 3": bolus calculator 171.3.3. Differences in the functions of modern insulin pumps 181.3.4. Use of the standard function of modern insulin pumps 191.3.5. Association of CSII and CGM for SAP 201.3.6. "Patch pumps" - insulin pumps without catheters 211.3.7. Implanted insulin pumps 221.4. Summary 231.5. References 232. Technical developments in the field of continuous glucose monitoring 262.1. Principles of the detection of glucose in blood or in interstitial fluid 262.2. Basic possibilities for continuous glucose monitoring (CGM) 282.2.1. Overview 282.2.2. Glucose monitoring in interstitial fluid with minimally invasive sensors 292.2.3. Glucose monitoring with implantable glucose sensors 302.2.4. Glucose monitoring with non-invasive glucose sensors 312.3. Properties and comparison of the available systems of the needle sensor type 332.4. References 383. Characteristics of continuous glucose monitoring (CGM) 423.1. Methods of CGM 423.1.1. Distinction between diagnostic and therapeutic use 423.1.2. Diagnostic application of CGM 423.1.3. Use of CGM in everyday treatment control 443.2. Differences in CGM in relation to self-monitoring of blood glucose (SMBG) 463.2.1. Uninterrupted measurement and visualisation of the dynamic glucose profile as a result of CGM 463.2.2. Consequences of CGM measurement in interstitial fluid 463.2.3. Calibration of CGM 473.2.4. Setting of alarms and pre-alarms 493.3. Utilisation of software for the display, analysis and evaluation of CGM measurements 503.3.1. Overview 503.3.2. Displays in CareLink(TM) software 513.3.2.1. CareLink(TM) PERSONAL 513.3.2.2. CareLink(TM) PRO 523.3.2.3. CareLink(TM) iPro(TM) 553.3.3. Summary 563.4. References 564. Aspects of the combination of glucose sensor and insulin pump 624.1. Potential of the combination of insulin pump and sensor 624.2. Support of CGM when starting a patient on insulin pump therapy 624.3. Utilisation of CGM profiles for training pump wearers 634.4. Influence of CGM on the full exploitation of the extended functions of modern insulin pumps 644.5. CGM as proof of successful pump initiation for the medical insurance companies 654.6. Sensor-augmented pump therapy (SAP) 664.7. Interconnection of glucose sensor and insulin pump for the closed loop system 694.8. References 725. Problem analysis from glucose profiles recorded with CGM 765.1. Overview 765.2. The magic of blood glucose and what interstitial glucose tells us about it 765.3. Hypoglycaemic episodes 775.3.1. Forensics with an evolutionary biological background 775.3.2. Classification of hypoglycaemia based on its symptoms 785.3.3. Clinical pathology of compromised counter-regulation 795.4. Use of CGM for the analysis of the glucose profile and detection of hypoglycaemia 795.5. Characteristic details in the CGM profiles 815.6. "Criminology" of the glucose level 835.6.1. Fine analysis of glucose profiles by "forensic detective work" 835.6.2. Criminology of nocturnal hypoglycaemia and its consequences 845.6.2.1. Possible motive and opportunity 845.6.2.2. From clues to the profile of the offender 845.6.2.3. Catching red-handed 855.6.2.4. Scene of the crime and search for tracks (standard pattern) 865.6.2.5. Disguises and deception 875.6.2.6. The usual suspects 895.6.2.7. Key points for "criminology" 895.6.3. Example of a patient 905.7. References 936. Getting started on sensor-augmented pump therapy 966.1. Overview 966.2. Insulin selection 966.3. Insulin dosage 976.3.1. Daily insulin requirement and its division 976.3.2. Basal rate 986.3.2.1. Determination of the basal rate 986.3.2.2. Checking the basal rate 986.3.2.3. Use of various basal rate profiles 986.3.2.4. Temporary basal rate 996.4. Bolus delivery 996.4.1. Bolus management 996.4.2. Bolus options 1006.4.3. Correction/bolus calculator, BolusWizard® 1026.5. References 1047. Clinical evidence on CSII, CGM and SAP 1087.1. Evidence-based medicine (EBM): how far can this be demanded for CSII, CGM and SAP? 1087.2. Clinical evidence on insulin pump therapy CSII 1107.2.1. Overview 1107.2.2. Experimental and clinical results of CSII in patients with type 1 diabetes 1107.2.3. Experimental and clinical results for CSII in patients with type 2 diabetes 1167.2.4. Meta-analyses on CSII 1177.3. Clinical evidence for continuous glucose monitoring (CGM) 1197.4. Experimental and clinical evidence for sensor-augmented pump therapy (SAP) 1237.5. References 1278. Is continuous glucose monitoring leading to a paradigm shift in diabetology? 1348.1. Empirical diabetology 1348.2. Diabetology based on data 1358.2.1. HbA1c and glucose excursions 1358.2.2. The glucose pentagon model 1368.3. Diabetology based on data in everyday practice 1388.4. Summary 1398.5. References 140 Index 142
mehr